Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2022-27883
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
A link following vulnerability in Trend Micro Antivirus for Mac 11.5 could allow an attacker to create a specially-crafted file as a symlink that can lead to privilege escalation. Please note that an attacker must at least have low-level privileges on the system to attempt to exploit this vulnerability.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Trend Micro Antivirus for Mac 后置链接漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Trend Micro Antivirus for Mac是美国趋势科技(Trend Micro)公司的一套基于Mac平台的杀毒软件。 Trend Micro Antivirus for Mac 2021(v11)版本存在安全漏洞,该漏洞源于本地用户可以创建指向系统上关键文件的特制符号链接,并使用应用程序的权限覆盖它。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
Trend MicroTrend Micro Antivirus for Mac 11.5 -
II. Public POCs for CVE-2022-27883
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2022-27883
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2022-27883

No comments yet


Leave a comment